The study by Linnerth-Petrik et al [42] which evaluated the impact of Akt2 loss in a viral lung cancer model did not directly compare AKT phosphorylation in parental and Akt2 null mice however, the levels of AKT phosphorylation were relatively consistent across tumors at different stages of development. The gene discussed is AKT2; the disease is lung cancer.